Hi Techtor & Everyone,
I am trying to reach statistics on the sexual enhancing drug- and
herbal-markets around the world. My focus is on the pill/tablet-format
meds (e.g., Viagra, Cialis, etc.) that are aimed to enhance male or
female sexual performance. A big plus if there is country-by-country
statistics on European and North American countries.
Octopia |
Request for Question Clarification by
techtor-ga
on
02 May 2006 03:05 PDT
Hmm,
Statistics are for the most part a most difficult thing to get from
the World Wide Web, though if someone has posted the needed statistics
by chance, then they're there. It'll be a longshot but I'll see what I
can dig up. Hope you could hang tight there.
|
Clarification of Question by
octopia-ga
on
02 May 2006 09:42 PDT
Yes, Techtor, I hear you. Let?s see how this will turn out. One plus
is that with the growing importance of this market and the emphasis
you see in the media, there must be some numbers posted somewhere.
Anyway, will hang in there as you advised.
|
Request for Question Clarification by
techtor-ga
on
04 May 2006 23:48 PDT
Octopia,
As I feared, getting general statistics on sex-enhancing drugs is
compounded by the observation that no one seems to have made a
statistical compilation of "sex-enhancing drugs" or same such blanket
category. It's always on the products, like Viagra, but even
statistics for one product like that are difficult to find. I'll try
to find out if there's another clue I haven't found.
|
Clarification of Question by
octopia-ga
on
09 May 2006 09:14 PDT
Hi Techtor,
OK, but it helps, we can narrow down the search to Viagra, Cialis, and
Levitra. I have found something interesting on:
http://www.nytimes.com/2005/12/04/business/yourmoney/04impotence.html?ex=1291352400&en=197ef4094a3660a9&ei=5088&partner=rssnyt&emc=rss
http://pubs.acs.org/cen/coverstory/83/8325/8325viagra.html
http://www.iht.com/articles/2003/02/05/drug_ed3_.php
but I was trying to get some indication of how much are thier sales in
Europe vs. the US.
Hope it makes it easier...
|
Request for Question Clarification by
techtor-ga
on
11 May 2006 23:07 PDT
I see. Thanks for that narrowing down. I'll give it a try then.
|
Request for Question Clarification by
techtor-ga
on
16 May 2006 00:02 PDT
Hi Octopia,
I've given it a try, and I haven't found breakdowns yet on sales of
each drug split between the US and Europe. So far only Lilly's figures
have been given about Cialis sales in a part of 2005, though still not
broken down between US and Europe. I found something here about
non-oral (non-pill) Erectile Dysfunction measures, the figures of
which are split between US and Europe for 2003:
http://www.ardana.co.uk/news21062004.html
Hope this will do for the moment.
|
Clarification of Question by
octopia-ga
on
22 May 2006 07:58 PDT
Hi Techtor,
Well, I got a good piece of information there, which is the worldwide market size.
However, that market (non-pills) is different from what I am looking
for, and might not give the right indication. Is there a way to find
out through Pfizer?s or Lilly?s website any indication of how big
their market is in Europe & the US? Does their annual report show this
info?
Thanks,
Octopia
|
Request for Question Clarification by
techtor-ga
on
22 May 2006 22:13 PDT
I'm looking for market size on pill products, but those seem pretty
much hidden. The market research books that cost hundreds or
thousands. When it comes to market size, Lilly is the only one that
readily gives its information. However, I'm looking and waiting to see
if more statistics will turn up in the news, or other such source.
|
Request for Question Clarification by
techtor-ga
on
28 May 2006 20:52 PDT
Hello Octopia,
So far, Lilly has the statistics you hope for about its Cialis product:
Lilly Posts Q4, 2005 Profit - Newsroom - Inside INdiana Business with Gerry Dick
http://www.insideindianabusiness.com/newsitem.asp?id=16591
?Worldwide Cialis sales are composed of $45.0 million of sales in
Lilly territories and $165.5 million of sales in the joint-venture
territories. Within the joint-venture territories, the U.S. sales of
Cialis were $81.6 million in the fourth quarter, a 55 percent increase
compared with fourth-quarter 2004 U.S. sales.
For the full year of 2005, Cialis worldwide sales increased 35
percent, to $746.6 million, of which $169.9 million represents sales
in Lilly territories and $576.7 million relates to sales in the
joint-venture territories. Within the joint-venture territories, the
U.S. sales of Cialis increased 32 percent, to $272.9 million, in
2005.?
Lilly Newsroom
http://www.prnewswire.com/cgi-bin/micro_stories.pl?ACCT=916306&TICK=LLY&STORY=/www/story/07-21-2005/0004071671&EDATE=Jul+21,+2005
- Gives easy to read figures, though only for US territory
I couldn't say the same for Levitra and Viagra. The statistics I could
find really focus on the company's financial status only, while no
drug statistics are given. I don't know if the controversy over the
products has affected these companies' desire to show figures.
Meanwhile, this comparative set of statistics from a news article
about 2004 sales might help.
Bayer buys back some Levitra rights - Pittsburgh Business Times
http://www.bizjournals.com/pittsburgh/stories/2005/01/10/daily6.html
?Levitra, which Glaxo launched in partnership with Bayer in the United
States in summer 2003 and Europe a few months later, generated sales
of just $60 million in the third quarter of last year. Pfizer Inc.'s
(NYSE:PFE) Viagra had sales of $305.3 million and Eli Lilly & Co.'s
(NYSE:LLY) Cialis had sales of $154 million.?
|
